Hearing News and Research

RSS

LecTec announces postponement of trial date

LecTec Corporation announced that in the patent infringement litigation entitled LecTec Corporation v. Chattem, Inc. et al. the parties met with the appointed judge for the United States District Court for the Eastern District of Texas. LecTec was informed at such hearing that due to a pending, unrelated, criminal matter, the trial date would be postponed from January 4, 2011 to Monday January 10, 2011.

4 Jan 2011

Researchers to identify gene variants that cause ischemic stroke

Researchers from the University of Maryland School of Medicine are coordinating an international team of scientists working to identify genes or gene variants that may make a person more likely to have a particular type of stroke called an ischemic stroke.

30 Dec 2010

Natus Medical ships ALGO hearing screeners to New South Wales

Natus Medical Incorporated today announced that it was awarded, and has shipped, a $1.3 million order for its ALGO hearing screeners from New South Wales, Australia's most populous state.

29 Dec 2010

Discovery Labs to implement reverse stock split

Discovery Laboratories, Inc. today announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the "Amendment") to effect a 1-for-15 share consolidation, or reverse stock split ("reverse split"), effective at 12:01 a.m. on December 28, 2010 (the "Effective Time").

28 Dec 2010

RegeneRx common stock to be quoted on OTC Bulletin Board following NYSE Amex suspension

RegeneRx Biopharmaceuticals, Inc. announced today that beginning with the opening of trading on December 23, 2010, the Company's common stock is expected to be quoted on the OTC Bulletin Board under the symbol RGRX following its suspension from the NYSE Amex as of that date.

24 Dec 2010

Ohio smokers lose big as 2-year legal battle comes to an end

The Ohio Supreme Court has ruled that the state had the authority to shut down the Ohio Tobacco Prevention Foundation (OTPF) in 2008 and divert Ohio's share of tobacco settlement funds to other budget items. For the state that ranks dead last in the amount of money it devotes to tackling smoking, the number one preventable cause of death, those who need help in quitting now have few places to turn.

23 Dec 2010

AADR testifies at FDA Advisory Panel meeting on dental amalgam

On December 14-15, 2010, the U.S. Food and Drug Administration (FDA) convened an Advisory Panel to discuss several scientific issues that may affect the regulation of dental amalgam. At the conclusion of the hearing, the Panel voted to recommend that the FDA conduct further review of the material's safety.

23 Dec 2010

Bloomberg: The politics, investments of judges

Three federal judges overseeing challenges to the Obama administration's health-care overhaul own shares of companies in the industry, including insurers and medical-device makers, the government watchdog group Center for Public Integrity reported.

23 Dec 2010

ARYx common stock listing to be transferred to NASDAQ Capital Market

ARYx Therapeutics, Inc. today announced that it has been notified by The NASDAQ Stock Market ("NASDAQ") that the listing of its common stock will be transferred from The NASDAQ Global Market to The NASDAQ Capital Market effective with the open of business today, December 21, 2010.

21 Dec 2010

Take charge of your medical tests

Whether you're healthy or ill, there are a variety of medical tests your health care team might recommend for you. A yearly checkup often includes routine tests such as blood sugar and cholesterol levels, vision and hearing assessments, tests for heart functioning and others used to monitor a chronic condition—such as a lung function test for those with asthma.

20 Dec 2010

FDA moves to curb Avastin's approval for breast cancer

The Food and Drug administration on Thursday revoked its approval of Roche drug Avastin for the treatment of breast cancer. The agency's action, based on findings that did not confirm that the medicine helped patients with this disease, has drawn criticism from patients and politicians.

20 Dec 2010

Genentech confirms EMA, FDA updates on Avastin for metastatic breast cancer

Genentech, a member of the Roche Group, confirmed that following the reviews of Avastin® (bevacizumab) in metastatic breast cancer by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), the following regulatory announcements were made by the individual health authorities:

17 Dec 2010

Iowa moves forward on health exchange; Texas medical school highlights geriatrics; Concerns grow about prisoners' mental health needs

Republican lawmakers on the state level are largely against the new health reform law—but they aren't against all of the behemoth legislation. Virginia dominated headlines this week when a federal judge ruled the individual mandate to buy insurance unconstitutional on Monday. Much less noticed: the very next day, a task force appointed by Republican Gov. Bob McDonnell recommended that the state implement a health insurance exchange earlier than federal guidelines require (Kliff, 12/16).

17 Dec 2010

Florida Judge hears arguments in 20-state health law challenge; says ruling will take time

The Associated Press: Attorneys for 20 states involved in a challenge to the new health law argued Thursday morning before U.S. District Judge Roger Vinson that it will "expand the government's powers in dangerous and unintended ways." The states were seeking "a summary judgment throwing out the health care law without a full trial. They argue it violates people's rights by forcing them to buy health insurance by 2014 or face penalties."

17 Dec 2010

FDA recommends removal of breast cancer indication from Avastin label

The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use.

17 Dec 2010

Health law challenges shift to Florida courtroom

Today marks a "new day in court" as oral arguments will be heard in a Florida courtroom regarding the 20-state legal challenge. This lawsuit includes issues surrounding the health law's individual mandate and Medicaid expansions. Meanwhile, analysis continues regarding Monday's decision by a federal court judge in Virginia and a new round of debate regarding whether the health overhaul lawsuits bring to light issues of judicial bias.

16 Dec 2010

Today's Opinions: Health law spending; Funding threats undercut U.S. legal tradition; Medicaid falls short

Rising entitlement spending is already driving the federal budget off a cliff. But Obamacare would add fuel to the fire with the largest entitlement expansion since the 1960s. So it takes a special kind of audacity for Obamacare's apologists to continue to insist that the new law will cut the projected budget deficits.

16 Dec 2010

Personalities, politics emerge from decision's aftermath

Personalities and politics swirl around news about Monday's ruling in the Virginia health law challenge, with news outlets detailing how judges in different cases reached their conclusions and examining Judge Henry Hudson's ties to a GOP consulting firm. More reports also surround the related political dust-ups and posturing.

16 Dec 2010

First Edition: December 15, 2010

Today's major health policy news is full of second-day stories and analysis regarding Monday's health law decision by a federal court judge in Virginia.

15 Dec 2010

OpEds: Assessing Judge Hudson's decision on individual mandate

In March, New Hampshire preschool teacher Gail O'Brien, who was unable to obtain health insurance through her employer, was diagnosed with an aggressive form of lymphoma. Her subsequent applications for health insurance were rejected because of her condition. With each round of chemotherapy costing $16,000, she delayed treatment because she knew her savings wouldn't last (Eric H. Holder and Kathleen Sebelius, 12/14).

14 Dec 2010